| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |